Developing a first-in-class drug for inflammatory disease europeanpharmaceuticalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europeanpharmaceuticalreview.com Daily Mail and Mail on Sunday newspapers.
- Company to share new positive, statistically significant results across Cohort 4 from Phase 2 study of MYMD-1 in sarcopenia, an age-related frailty disorder -
.
Baltimore company designing rheumatoid arthritis drug gets OK from FDA to start testing on patients baltimoresun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from baltimoresun.com Daily Mail and Mail on Sunday newspapers.